Milrinone improves oxygenation in neonates with severe persistent pulmonary hypertension of the newborn

Journal of Critical Care

Volumn 21, Issue 2, 2006, Pages 217-222

  McNamara, Patrick J ^a   Laique, Firdous ^a   Muang In, Sataporn ^a   Whyte, Hilary E ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

Milrinone; Myocardial dysfunction; Oxygenation failure; Persistent pulmonary hypertension of the newborn

Indexed keywords

INOTROPIC AGENT; MILRINONE; NITRIC OXIDE; VASODILATOR AGENT;

ADD ON THERAPY; ANTIHYPERTENSIVE THERAPY; ARTICLE; BIRTH WEIGHT; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE COURSE; DISEASE SEVERITY; DRUG EFFECT; DRUG EFFICACY; DRUG RESPONSE; ECHOCARDIOGRAPHY; GESTATIONAL AGE; HEART RATE; HEMODYNAMICS; HUMAN; HYPOTENSION; MAJOR CLINICAL STUDY; NEWBORN; NEWBORN DISEASE; NEWBORN INTENSIVE CARE; OXYGENATION; PULMONARY HYPERTENSION; TREATMENT DURATION; TREATMENT FAILURE; VASODILATATION;

CYCLIC AMP; CYCLIC GMP; HUMANS; HYPERTENSION, PULMONARY; INFANT, NEWBORN; MILRINONE; OXYGEN; PHOSPHODIESTERASE INHIBITORS; SIGNAL TRANSDUCTION; VASODILATOR AGENTS;

EID: 33744945524     PISSN: 08839441     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcrc.2006.01.001     Document Type: Article

References (38)

1. Murphy J.D., Rabinovitch M., Goldstein J.D., and Reid L.M. The structural basis of persistent pulmonary hypertension of the newborn infant. J Pediatr 98 6 (1981) 962-967
2. Walsh-Sukys M.C., Tyson J.E., Wright L.L., Bauer C.R., Korones S.B., Stevenson D.K., et al. Persistent pulmonary hypertension of the newborn in the era before nitric oxide: practice variation and outcomes. Pediatrics 105 1 Pt 1 (2000) 14-20
3. Finer N.N., and Barrington K.J. Nitric oxide for respiratory failure in infants born at or near term. Cochrane Database Syst Rev 4 (2001) CD000399
4. Hintz S.R., Suttner D.M., Sheehan A.M., Rhine W.D., and Van Meurs K.P. Decreased use of neonatal extracorporeal membrane oxygenation (ECMO): how new treatment modalities have affected ECMO utilization. Pediatrics 106 6 (2000) 1339-1343
5. Goldman A.P., Tasker R.C., Haworth S.G., Sigston P.E., and Macrae D.J. Four patterns of response to inhaled nitric oxide for persistent pulmonary hypertension of the newborn. Pediatrics 98 4 Pt 1 (1996) 706-713
6. Chen E.P., Bittner H.B., Davis Jr. R.D., and Van III T.P. Milrinone improves pulmonary hemodynamics and right ventricular function in chronic pulmonary hypertension. Ann Thorac Surg 63 3 (1997) 814-821
7. Chen E.P., Bittner H.B., Davis R.D., and Van Trigt P. Hemodynamic and inotropic effects of milrinone after heart transplantation in the setting of recipient pulmonary hypertension. J Heart Lung Transplant 17 7 (1998) 669-678
8. Kato R., Sato J., and Nishino T. Milrinone decreases both pulmonary arterial and venous resistances in the hypoxic dog. Br J Anaesth 81 6 (1998) 920-924
9. George M., Lehot J.J., and Estanove S. Haemodynamic and biological effects of intravenous milrinone in patients with a low cardiac output syndrome following cardiac surgery: multicentre study. Eur J Anaesthesiol Suppl 5 (1992) 31-34
10. Haraldsson sA., Kieler-Jensen N., and Ricksten S.E. The additive pulmonary vasodilatory effects of inhaled prostacyclin and inhaled milrinone in postcardiac surgical patients with pulmonary hypertension. Anesth Analg 93 6 (2001) 1439-1445 [table]
11. Chang A.C., Atz A.M., Wernovsky G., Burke R.P., and Wessel D.L. Milrinone: systemic and pulmonary hemodynamic effects in neonates after cardiac surgery. Crit Care Med 23 11 (1995) 1907-1914
12. Development of audit measures and guidelines for good practice in the management of neonatal respiratory distress syndrome. Report of a joint working group of the British Association of Perinatal Medicine and the Research Unit of the Royal College of Physicians. Arch Dis Child 67 10 Spec No (1992) 1221-1227
13. Inhaled nitric oxide in full-term and nearly full-term infants with hypoxic respiratory failure. The Neonatal Inhaled Nitric Oxide Study Group. N Engl J Med 336 9 (1997) 597-604
14. Gupta A., Rastogi S., Sahni R., Bhutada A., Bateman D., Rastogi D., et al. Inhaled nitric oxide and gentle ventilation in the treatment of pulmonary hypertension of the newborn-a single-center, 5-year experience. J Perinatol 22 6 (2002) 435-441
15. Roberts Jr. J.D., Fineman J.R., Morin III F.C., Shaul P.W., Rimar S., Schreiber M.D., et al. Inhaled nitric oxide and persistent pulmonary hypertension of the newborn. The Inhaled Nitric Oxide Study Group. N Engl J Med 336 9 (1997) 605-610
16. Heal C.A., and Spencer S.A. Methaemoglobinaemia with high-dose nitric oxide administration. Acta Paediatr 84 11 (1995) 1318-1319
17. Wedgwood S., McMullan D.M., Bekker J.M., Fineman J.R., and Black S.M. Role for endothelin-1-induced superoxide and peroxynitrite production in rebound pulmonary hypertension associated with inhaled nitric oxide therapy. Circ Res 89 4 (2001) 357-364
18. Haddad I.Y., Ischiropoulos H., Holm B.A., Beckman J.S., Baker J.R., and Matalon S. Mechanisms of peroxynitrite-induced injury to pulmonary surfactants. Am J Physiol 265 6 Pt 1 (1993) L555-L564
19. Jentzer J.H., LeJemtel T.H., Sonnenblick E.H., and Kirk E.S. Beneficial effect of amrinone on myocardial oxygen consumption during acute left ventricular failure in dogs. Am J Cardiol 48 1 (1981) 75-83
20. Rabe K.F., Tenor H., Dent G., Schudt C., Nakashima M., and Magnussen H. Identification of PDE isozymes in human pulmonary artery and effect of selective PDE inhibitors. Am J Physiol 266 5 Pt 1 (1994) L536-L543
21. LeJemtel T.H., Scortichini D., Levitt B., and Sonnenblick E.H. Effects of phosphodiesterase inhibition on skeletal muscle vasculature. Am J Cardiol 63 2 (1989) 27A-30A
22. Silver P.J., Harris A.L., Canniff P.C., Lepore R.E., Bentley R.G., Hamel L.T., et al. Phosphodiesterase isozyme inhibition, activation of the cAMP system, and positive inotropy mediated by milrinone in isolated guinea pig cardiac muscle. J Cardiovasc Pharmacol 13 4 (1989) 530-540
23. Wynands J.E. Amrinone: is it the inotrope of choice?. J Cardiothorac Anesth 3 6 Suppl 2 (1989) 45-57
24. Wagner R.S., Smith C.J., Taylor A.M., and Rhoades R.A. Phosphodiesterase inhibition improves agonist-induced relaxation of hypertensive pulmonary arteries. J Pharmacol Exp Ther 282 3 (1997) 1650-1657
25. Artman M., Kithas P.A., Wike J.S., and Strada S.J. Inotropic responses change during postnatal maturation in rabbit. Am J Physiol 255 2 Pt 2 (1988) H335-H342
26. Binah O., Sodowick B., Vulliemoz Y., Danilo Jr. P., and Rosen M. The inotropic effects of amrinone and milrinone on neonatal and young canine cardiac muscle. Circulation 73 3 Pt 2 (1986) III46-III51
27. Ross-Ascuitto N.T., Ascuitto R.J., Ramage D., and McDonough K.H. The effects of milrinone in the neonatal pig heart. Cardiovasc Drugs Ther 5 6 (1991) 1011-1019
28. Hoffman T.M., Wernovsky G., Atz A.M., Kulik T.J., Nelson D.P., Chang A.C., et al. Efficacy and safety of milrinone in preventing low cardiac output syndrome in infants and children after corrective surgery for congenital heart disease. Circulation 107 7 (2003) 996-1002
29. Deb B., Bradford K., and Pearl R.G. Additive effects of inhaled nitric oxide and intravenous milrinone in experimental pulmonary hypertension. Crit Care Med 28 3 (2000) 795-799
30. Khazin V., Kaufman Y., Zabeeda D., Medalion B., Sasson L., Schachner A., et al. Milrinone and nitric oxide: combined effect on pulmonary artery pressures after cardiopulmonary bypass in children. J Cardiothorac Vasc Anesth 18 2 (2004) 156-159
31. Kelly L.K., Porta N.F., Goodman D.M., Carroll C.L., and Steinhorn R.H. Inhaled prostacyclin for term infants with persistent pulmonary hypertension refractory to inhaled nitric oxide. J Pediatr 141 6 (2002) 830-832
32. + current in single heart cells. Nature 323 6085 (1986) 273-275
33. Mery P.F., Pavoine C., Belhassen L., Pecker F., and Fischmeister R. Nitric oxide regulates cardiac Ca2+ current. Involvement of cGMP-inhibited and cGMP-stimulated phosphodiesterases through guanylyl cyclase activation. J Biol Chem 268 35 (1993) 26286-26295
34. Goldstein D.J., Dean D.A., Smerling A., Oz M.C., Burkhoff D., and Dickstein M.L. Inhaled nitric oxide is not a negative inotropic agent in a porcine model of pulmonary hypertension. J Thorac Cardiovasc Surg 114 3 (1997) 461-466
35. Cheung P.Y., and Barrington K.J. The effects of dopamine and epinephrine on hemodynamics and oxygen metabolism in hypoxic anesthetized piglets. Crit Care 5 3 (2001) 158-166
36. Barrington K.J., Finer N.N., and Chan W.K. A blind, randomized comparison of the circulatory effects of dopamine and epinephrine infusions in the newborn piglet during normoxia and hypoxia. Crit Care Med 23 4 (1995) 740-748
37. Evans N., Kluckow M., and Currie A. Range of echocardiographic findings in term neonates with high oxygen requirements. Arch Dis Child Fetal Neonatal Ed 78 2 (1998) F105-F111
38. Turbow R., Waffarn F., Yang L., Sills J., and Hallman M. Variable oxygenation response to inhaled nitric oxide in severe persistent pulmonary hypertension of the newborn. Acta Paediatr 84 11 (1995) 1305-1308